ViroGates Overview

  • Founded
  • 2001
  • Status
  • Public
  • Employees
  • 14
  • Stock Symbol
  • VIRO
Stock Symbol
  • Share Price
  • $27.69
  • (As of Wednesday Closing)

ViroGates General Information


ViroGates AS is a life science company which develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, cancer. Its has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision making.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Monitoring Equipment
Stock Exchange
Primary Office
  • Blokken 45
  • 3460 Birkerød
  • Denmark
+45 21 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ViroGates Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$27.69 $27.07 $8.77 - $40.71 $83.9M 3.03M 4.32K -$0.84

ViroGates Financials Summary

In Thousands,
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 80,104 36,071 8,625 18,128
Revenue 1,093 818 537 525
EBITDA (2,791) (2,981) (2,940) (2,846)
Net Income (2,632) (2,864) (2,818) (2,689)
Total Assets 4,678 6,321 6,770 9,716
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ViroGates Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ViroGates‘s full profile, request access.

Request a free trial

ViroGates Executive Team (6)

Name Title Board Seat Contact Info
Jakob Knudsen Chief Executive Officer
May Dyvelkov Chief Financial Officer
Jesper Eugen-Olsen Ph.D Co-Founder & Chief Scientific Officer
Peter Benson Co-Founder
Thomas Krarup Ph.D Vice President, Global Sales & Marketing
You’re viewing 5 of 6 executive team members. Get the full list »

ViroGates Board Members (4)

Name Representing Role Since
Bernd Uder Self Board Member 000 0000
Jørgen Thorball MD Self Co-Founder & Board Member 000 0000
Lars Kongsbak Ph.D Self Chairman 000 0000
Lars Krogsgaard Self Board Member 000 0000
To view ViroGates’s complete board members history, request access »

ViroGates Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ViroGates Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ViroGates‘s full profile, request access.

Request a free trial